Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
Open Access
- 15 September 1995
- Vol. 76 (6), 998-1005
- https://doi.org/10.1002/1097-0142(19950915)76:6<998::aid-cncr2820760613>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Biology and biochemistry of proteinases in tumor invasionPhysiological Reviews, 1993
- The plasminogen-plasmin system in malignancyCancer and Metastasis Reviews, 1992
- Increase of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in plasma after thrombolytic therapy of patients with myocardial infarction. A randomised, placebo-controlled studyFibrinolysis, 1992
- Plasminogen Activator Inhibitor Type 1: Biochemistry and Evidence for Modulation of Fibrinolysis In VivoSeminars in Thrombosis and Hemostasis, 1992
- The plasminogen activator/plasmin system.Journal of Clinical Investigation, 1991
- Plasminogen Activation by Receptor-Bound UrokinaseSeminars in Thrombosis and Hemostasis, 1991
- The urokinase receptor and regulation of cell surface plasminogen activationCell Differentiation and Development, 1990
- The role of urokinase-type plasminogen activator in aggressive tumor cell behaviorCancer and Metastasis Reviews, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988